Technology development for Sr-89 production with 100kW medical isotope production system (MIPS-100). Final CRADA Report.
Abstract
No abstract prepared.
- Authors:
- Publication Date:
- Research Org.:
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Sponsoring Org.:
- USDOE National Nuclear Security Administration (NNSA)
- OSTI Identifier:
- 967951
- Report Number(s):
- ANL/NE-C0000401
TRN: US0904527
- DOE Contract Number:
- DE-AC02-06CH11357
- Resource Type:
- Technical Report
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 38 RADIATION CHEMISTRY, RADIOCHEMISTRY, AND NUCLEAR CHEMISTRY; ISOTOPE PRODUCTION; STRONTIUM 89; TECHNOLOGY UTILIZATION
Citation Formats
Ehst, D. A., and Nuclear Engineering Division. Technology development for Sr-89 production with 100kW medical isotope production system (MIPS-100). Final CRADA Report.. United States: N. p., 2009.
Web. doi:10.2172/967951.
Ehst, D. A., & Nuclear Engineering Division. Technology development for Sr-89 production with 100kW medical isotope production system (MIPS-100). Final CRADA Report.. United States. doi:10.2172/967951.
Ehst, D. A., and Nuclear Engineering Division. Fri .
"Technology development for Sr-89 production with 100kW medical isotope production system (MIPS-100). Final CRADA Report.". United States.
doi:10.2172/967951. https://www.osti.gov/servlets/purl/967951.
@article{osti_967951,
title = {Technology development for Sr-89 production with 100kW medical isotope production system (MIPS-100). Final CRADA Report.},
author = {Ehst, D. A. and Nuclear Engineering Division},
abstractNote = {No abstract prepared.},
doi = {10.2172/967951},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Fri Oct 02 00:00:00 EDT 2009},
month = {Fri Oct 02 00:00:00 EDT 2009}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
-
Development of Carbon-14 Waste Destruction and Recovery System Using AC Plasma Torch Technology Final Report CRADA No. TC02108.0
This was a collaborative effort between Lawrence Livermore National Security, LLC as manager and operator of Lawrence Livermore National Laboratory (LLNL) and ISOFLEX USA (ISOFLEX), to 1) develop and test a prototype waste destruction system ("System") using AC plasma torch technology to break down and drastically reduce the volume of Carbon-14 (C-14) contaminated medical laboratory wastes while satisfying all environmental regulations, and 2) develop and demonstrate methods for recovering 99%+ of the carbon including the C-14 allowing for possible re-use as a tagging and labeling tool in the biomedical industry. -
Medical Isotope Program: O-18, C-13, and Xe-129 Final Report CRADA No. TC-2043-02
This was a collaborative effort between the University of California, Lawrence Livermore National Laboratory (LLNL) and Spectra Gases, Inc., to develop new and cheaper sources of Oxgyen-18 (O-18), Carbon-13 (C-13), and Xenon-129 (Xe-129), and to develop new applications of these stable medical isotopes in medicine resulting in a substantial increase in stable isotopes that are important to human health sciences. -
Administrative and technical support for the U. S. Army Medical Research and Development Command Joint Working Group on medical chemical defense. Final report, 15 Aug 84-14 Aug 89
The Joint Working Group on Drug Dependent Degradation in Military Performance (JWGD MILPERS) program was established by the U.S. Army Medical Research and Development Command (USAMRDC) as a tri-service program charged with developing and testing performance methodologies for evaluating the effects on military performance from medical treatment and pretreatment drugs used to counter chemical warfare agents. Metters Industries, Inc. provided administrative and technical support to the JWGD3 including opening and operating the JWGD3 MILPERS Field office, developing and maintaining program planning documents including budget and resource requirements, initiating and coordinating contract and MIPR documents on program projects, developing and maintainingmore » -
The final technical report of the CRADA, 'Medical Accelerator Technology'
Under this CRADA, Berkeley Lab and the industry partner, General Atomics (GA), have cooperatively developed hadron therapy technologies for commercialization. Specifically, Berkeley Lab and GA jointly developed beam transport systems to bring the extracted protons from the accelerator to the treatment rooms, rotating gantries to aim the treatment beams precisely into patients from any angle, and patient positioners to align the patient accurately relative to the treatment beams. We have also jointly developed a patient treatment delivery system that controls the radiation doses in the patient, and hardware to improve the accelerator performances, including a radio-frequency ion source and itsmore »